(-0.09%) 5 464.35 points
(-0.09%) 39 079 points
(0.16%) 17 746 points
(-0.58%) $80.36
(-4.32%) $2.64
(-0.85%) $2 310.90
(-0.05%) $28.86
(2.30%) $1 009.10
(0.30%) $0.936
(0.73%) $10.68
(0.48%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases...
Stats | |
---|---|
Today's Volume | 116 690 |
Average Volume | 171 415 |
Market Cap | 550.43M |
EPS | $-0.000200 ( Q3 | 2023-11-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.331 (5.64%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-05-17 | Lowenthal Richard E | Sell | 1 050 000 | Common Stock |
2023-05-17 | Lowenthal Richard E | Sell | 1 050 000 | Common Stock |
2023-05-17 | Lowenthal Richard E | Buy | 1 050 000 | Common Stock |
2023-05-17 | Lowenthal Richard E | Buy | 1 050 000 | Common Stock |
2024-01-02 | Lowenthal Richard E | Buy | 880 000 | Stock option (right to buy) |
INSIDER POWER |
---|
71.64 |
Last 97 transactions |
Buy: 39 434 245 | Sell: 5 326 539 |
Volume Correlation
Silverback Therapeutics, Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Silverback Therapeutics, Correlation - Currency/Commodity
Silverback Therapeutics, Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.850 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.850 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-30.77 |
FY | 2020 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-11.33 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Silverback Therapeutics,
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators